Friends Research Institute
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Friends Research Institute sits in the top decile of US sponsors by registered trial count (#429 of 15,742 sponsors by registered trial count).
Friends Research Institute: 41 sponsored US clinical trials, 5 recruiting.
Friends Research Institute sponsors 41 registered US clinical trials on ClinicalTrials.gov, 5 of them currently recruiting, and 30 completed. 8 of these trials are in Phase 3-4 (later-stage) and 7 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Opioid Use Disorder, with 10 trials.
Top-decile sponsor footprint
Friends Research Institute ranks in the top decile of sponsors by registered trial count (#429 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
30 of 32 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (93.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
41 total, page 1 of 1
NavSTAR Implementation Effectiveness Trial Across a Health System
NCT07262190
Buprenorphine for Individuals in Jail
NCT06306443
Addressing Racial Disparities in Opioid Overdose Using Peer Recovery Coach Training and mHealth Platform
NCT06573476
Using AI and Peer Coaching to Address Racial Disparities Among People Who Use Opioids
NCT06569667
Treating Polysubstance Use Using a Novel Digital Technology
NCT05766631
Telemedicine XR-B for Individuals in Jail
NCT07524738
Low-dose Versus a High-dose Sublingual Buprenorphine Induction
NCT05944952
Using the Ending Self-Stigma Intervention to Reduce Internalized Stigma Among People Living With HIV Who Use Substances
NCT05704764
Extended Release Naltrexone Versus Extended Release Buprenorphine With Individuals Leaving Jail
NCT04408313
Continuing Care for Justice-involved Individuals
NCT07593274
Philly NavSTAR Implementation Trial
NCT06634277
Optimal Intervention to Full Viral Suppression: Text Me, Alexis!
NCT06408350
ASK-PrEP (Assistance Services Knowledge-PrEP)
NCT05934877
Opioid Use Disorder Treatment Linkage at Strategic Touchpoints Using Buprenorphine
NCT04991974
Opioid Treatment Program (OTP)-Pharmacy Collaboration for Methadone Maintenance Treatment
NCT04308694
Facilitating the Implementation of Interim Methadone to Increase Treatment Access
NCT04188977
TechStep: Technology-based Stepped Care to Stem Transgender Adolescent Risk Transmission
NCT04000724
Embedding Comprehensive Smoking Cessation Programs Into Community Clinics
NCT04717544
Depression Intervention Among Gay and Bisexual Men Receiving Treatment for Methamphetamine Use
NCT03864653
The Getting Off App for Methamphetamine-Using Gay and Bisexual Men
NCT03884946
Examining the Effectiveness of the FaCES Adolescent SBIRT Intervention
NCT04097964
Pharmacokinetics of Nicotine Sublingual Tablets Versus Nicorette Lozenge in Healthy Smokers
NCT02906995
Long-acting Naltrexone for Pre-release Prisoners
NCT02867124
Navigation Services to Avoid Rehospitalization (NavSTAR)
NCT02599818
A Randomized Trial of Interim Methadone and Patient Navigation Initiated in Jail
NCT02334215
The Tobacco, Alcohol, Prescription Medication and Other Substances Tool
NCT02110693
Theory-based Text Messaging to Reduce Methamphetamine Use and HIV Risks Among MSM
NCT02008526
Computerized Brief Intervention vs. Delayed Computerized Brief Intervention
NCT01936623
Extended Release Naltrexone for Opioid-Dependent Youth
NCT01843023
SBIRT Implementation for Adolescents in Urban Federally Qualified Health Centers
NCT01829308
Reengineering Methadone Treatment Study of Patient-centered Methadone Treatment
NCT01442493
A Randomized Controlled Trial of HIV Testing and Linkage to Care at Community Corrections
NCT01366495
Screening Brief Intervention Referral to Treatment (SBIRT) in New Mexico
NCT01131520
Biobehavioral Interventions for HIV-negative, Stimulant Using Men Who Have Sex With Men
NCT01140880
Intensive Outpatient Versus Outpatient Treatment With Buprenorphine Among African Americans
NCT01096550
Contingency Management for Methamphetamine Abstinence and HIV Post-Exposure Prophylaxis in Men Who Have Sex With Men
NCT00856323
Buprenorphine for Prisoners
NCT00574067
Entry Into Comprehensive Methadone Treatment Via Interim Maintenance
NCT00712036
Voucher-Based Incentives in a Prevention Setting
NCT00607269
Long-term Behavior Change - 1
NCT00158197
Methadone Maintenance for Prisoners
NCT00378079
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 5 |
| Phase 3 | 6 |
| Phase 4 | 2 |
Therapeutic Areas
What is open in the Friends Research Institute pipeline
5 recruiting of 41 indexed (12% open); 30 completed (73%).
Phase mix: 8 late (III/IV) vs 7 early (I/II) (balanced across stages).
Top condition: Opioid Use Disorder (10 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Friends Research Institute: open-pipeline peers nationwide
Peers matched on 41 registered trials and 12% open enrollment, not the therapeutic-area sidebar.
Friends Research Institute sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 41 trials (± recruiting share)
- Bavarian Nordic · 41 trials · 5% recruiting
- Scripps Translational Science Institute · 41 trials · 20% recruiting
- Solventum US · 41 trials · 5% recruiting
- United States Naval Medical Center, San Diego · 41 trials · 15% recruiting
Sponsors near 12% open enrollment (± trial volume)
- Dartmouth-Hitchcock Medical Center · 12% recruiting · 427 trials
- National Institute of Mental Health (NIMH) · 12% recruiting · 343 trials
- Augusta University · 12% recruiting · 106 trials
- Antonios Likourezos · 12% recruiting · 33 trials
Related
What to do with this Friends Research Institute page
41 registered trials is a research-attention snapshot, not an endorsement of Friends Research Institute or any single study.
- 5 of Friends Research Institute's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Opioid Use Disorder is the condition Friends Research Institute studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Opioid Use Disorder trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Friends Research Institute pipeline card: 41 registered trials from official public datasets.Report a data error.